Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer

References

• Andrievski A, Wilkins RC. 2009. The response of γ-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures. International Journal of Radiation Biology 85:369–376.
   PubMed Web of Science ®Google Scholar
• Antonelli F, Belli M, Cuttone G, Dini V, Esposito G, Simone G, Sorrentino E, Tabocchini A. 2005. Induction and repair of DNA double-strand breaks in human cells: Dephosphorylation of histone H2AX and its inhibition by Cacyculin A. Radiation Research 164:514–517.
   PubMed Web of Science ®Google Scholar
• Banáth JP, MacPhail SH, Olive PL. 2004. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Research 64:7144–7149.
   PubMed Web of Science ®Google Scholar
• Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlasakova K, Livingston DM, Ferguson DO, Scully R, Alt FW. 2002. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proceedings of the National Academy of Sciences of the USA 99:8173–8178.
   PubMed Web of Science ®Google Scholar
• Bourguignon MH, Gisone PA, Perez MR, Michelins S, Dubner D, Giorgio MD, Carosella ED. 2005. Genetic and epigenetic features in radiation sensitivity. Part II: Implications for clinical practice and radiation protection. European Journal of Nuclear Medicine and Molecular Imaging 32:351–368.
   PubMedGoogle Scholar
• Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nature Cell Biology 5:675–679.
   PubMed Web of Science ®Google Scholar
• Chun HH, Gatti RA. 2004. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 3:1187–1196.
   PubMed Web of Science ®Google Scholar
• Corvò R. 2007. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology 85:156–170.
   PubMed Web of Science ®Google Scholar
• De Neve W. 2006. Rationale of intensity modulated radiation therapy: A clinician's point of view. In: Bortfeld T, Schmidt-Ullrich R, De Neve W, Wazer DE, editors. Image-guided IMRT. Berlin: Springer-Verlag. p; p 3–9.
   Google Scholar
• Ding M, Newman F, Raben D. 2005. New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngologic Clinics of North America 38:371–395.
   PubMedGoogle Scholar
• Dirix P, Nuyts S. 2010. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncology 11:985–991.
   Google Scholar
• Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Mandani I. 2010. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. International Journal of Radiation Oncology Biology Physics. (in press).
   Google Scholar
• Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, Marsh R, Pameijer FA, Balm AJM. 2004. Dysphagia and aspiration after chemotherapy for head and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? International Journal of Radiation Oncology Biology Physics 60:1425–1439.
   PubMed Web of Science ®Google Scholar
• FitzGerald MD, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin DP. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genetics 15:307–310.
   PubMed Web of Science ®Google Scholar
• Giro C, Berger V, Bölke E, Ciernik F, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W. 2009. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes. Radiotherapy and Oncology 90:166–171.
   PubMed Web of Science ®Google Scholar
• Hymes SR, Strom EA, Fife C. 2006. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology 54:28–46.
   PubMed Web of Science ®Google Scholar
• Kato TA, Nagasawa H, Weil MM, Little JB, Bedford JS. 2006. Levels of γ-H2AX foci after low-dose-rate irradiation reveal a DNA DSB rejoining defect in cells from human ATM heterozygotes in two AT families and in another apparently normal individual. Radiation Research 166:443–453.
   PubMed Web of Science ®Google Scholar
• Klokov D, MacPhail SM, Banáth JP, Byrne JP, Olive PL. 2006. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiotherapy and Oncology 80:223–229.
   PubMed Web of Science ®Google Scholar
• Kühne M, Riballo E, Rief N, Rothkamm K, Jeggo PA, Löbrich M. 2004. A double strand break repair defect in ATM deficient cells contributes to radiosensitivity. Cancer Research 64:500–508.
   PubMed Web of Science ®Google Scholar
• Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJM, Kolkman Deurloo I, Prevost J, Poll J, Schmitz PIM, Heijmen BJ. 2007. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiotherapy and Oncology 85:64–73.
   PubMed Web of Science ®Google Scholar
• Löbrich M, Rief N, Kühne M, Heckmann M, Fleckenstein J, Rübe C, Uder M. 2005. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proceedings of the National Academy of Sciences of the USA 102:8984–8989.
   PubMed Web of Science ®Google Scholar
• MacPhail SH, Banáth JP, Yu TY, Chu EHM, Lambur H, Olive PL. 2003. Expression of hosphorylated histone H2AX in cultured cell lines following exposure to X-rays. International Journal of Radiation Biology 79:351–358.
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, Jacobs F, Grégoire V, Lonneux M, Vakaet L, Vanderstraeten B, Bauters W, Bonte K, Thierens H, De Neve W. 2007. Positron emission tomography-guided, focal-dose escalation using intensity modulated radiotherapy for head and neck cancer. International Journal of Radiation Oncology Biology Physics 68:126–135.
   PubMed Web of Science ®Google Scholar
• Mahrhofer HM, Bürger S, Oppitz U, Flentje M, Djuzenova CS. 2006. Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. International Journal of Radiation Oncology Biology Physics 64:573–580.
   PubMed Web of Science ®Google Scholar
• Menegakis A, Yaromina A, Eicheler W, Dörfler A, Beuthien-Baumann B, Thames HD, Baumann M, Krause M. 2009. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining. International Journal of Radiation Biology 85:1032–1041.
   PubMed Web of Science ®Google Scholar
• Murphy BA, Gilbert J. 2009. Dysphagia in head and neck cancer patients treated with radiation: Assessment, sequelae and rehabilitation. Seminars in Radiation Oncology 19:35–42.
   PubMed Web of Science ®Google Scholar
• Murphy BA, Gilbert J, Cmelak A, Ridner SH. 2007. Symptom control issues and supportive care for patients with head and neck cancers. Clinical Advances in Hematology and Oncology 5:807–822.
   PubMedGoogle Scholar
• Olive PL, Banáth J. 2004. Phosphorylation of histone H2AX as a measure of radiosensitivity. International Journal of Radiation Oncology Biology Physics 58:331–335.
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP, Keyes M. 2008. Residual γH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiotherapy and Oncology 86:336–346.
   PubMed Web of Science ®Google Scholar
• Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 10:886–895.
   PubMed Web of Science ®Google Scholar
• Pignon J, le Maître A, Maillard E, Bouhis J, on behalf of the MACH-NC Collaborative Group. 2009. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology 92:4–14.
   PubMed Web of Science ®Google Scholar
• Platteaux N, Dirix P, Dejaeger E, Nuyts S. 2009. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia. Online Publication: PMID: 19711127.
   Google Scholar
• Porcedda P,Turinetto V, Brusco A, Cavalieri S, Lantelme E, Orlando L, Ricardi U, Amoroso A, Gregori D, Giachino C. 2008. A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia. Cytometry Part A 73A:508–516.
   Google Scholar
• Rogakou EP, Boon C, Redon C, Bonner WM. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo.Journal of Cell Biology 146:905–915.
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on Serine 139. Journal of Biological Chemistry 273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Lewin JS, Eisbruch A. 2006. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. Journal of Clinical Oncology 24:2636–2643.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Trotti A. 2009. Strategies for managing radiation-induced mucositis in head and neck cancer. Seminars in Radiation Oncology 19:29–34.
   PubMed Web of Science ®Google Scholar
• Rübe CE, Grudzenski S, Kühne M, Dong X, Rief N, Löbrich M, Rübe C. 2008. DNA double strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: Implications for radiosensitivity testing. Clinical Cancer Research 14:6546–6555.
   PubMed Web of Science ®Google Scholar
• Rübe CE, Fricke A, Schneider R, Simon K, Kühne M, Fleckenstein J, Gräber S, Graf N, Rübe C. 2010. DNA repair alterations in children with pediatric malignancies: Novel opportunities to identify patients at risk for high-grade toxicities. International Journal of Radiation Oncology Biology Physics. (In press).
   Google Scholar
• Stucki M, Jackson SP. 2006. γH2AX and MDC1: Anchoring the DNA-damage response machinery to broken chromosomes. DNA Repair 5:534–543.
   PubMed Web of Science ®Google Scholar
• Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. 2002. Quantitative detection of 125IdU-induced DNA double-strand breaks with γH2AX antibody. Radiation Research 158:486–492.
   PubMed Web of Science ®Google Scholar
• Sonis ST. 2004. The pathobioloby of cancer. Nature Reviews Cancer 4:277–284.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Ohnishi T. 2005. Does γH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Letters 229:171–179.
   PubMed Web of Science ®Google Scholar
• Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ, Weichselbaum RR. 2004. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. Journal of Biological Chemistry 279:2273–2280.
   PubMed Web of Science ®Google Scholar
• Turesson I, Nyman J, Holmberg E, Oden A. 1996. Prognostic factors for acute and late skin reactions in radiotherapy patients. International Journal of Radiation Oncology Biology Physics 36:1065–1075.
   PubMed Web of Science ®Google Scholar
• Vasireddy RS, Sprung CN, Cempaka NL, Chao M, McKay MJ. 2010. H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand bread repair cellular phenotype. British Journal of Cancer 102:1511–1518.
   PubMed Web of Science ®Google Scholar
• Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. 2008. Evidence behind use of intensity-modulated radiotherapy: A systematic review of comparative clinical studies. Lancet Oncology 9:367–375.
   PubMed Web of Science ®Google Scholar
• Weissberg JB, Huang D, Swift M. 1998. Radiosensitivity of normal tissues in ataxia telangiectasia heterozygotes. International Journal of Radiation Oncology Biology Physics 42:1133–1136.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, De Neve W, Thierens H. 2010. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: Potential of the γ-H2AX foci assay and association with chromosomal radiosensitivity. Oncology Reports 23:571–578.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, van Eijkeren M, Boterberg T, Willems P, Vral A, De Neve W, Thierens H. 2009. Acute normal tissue reactions in head-and neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes. International Journal of Radiation Oncology Biology Physics 73:1187–1195.
   PubMed Web of Science ®Google Scholar